Screener Summaries Updates Institutions Sign In More Updates › Leadership & Pay › NTRA Leadership & Pay · Jun 16, 2026
Natera, Inc. expanded its Board of Directors from eleven to twelve members and appointed Thomas Lynch as a Class I… NTRA Natera, Inc.
Natera, Inc. expanded its Board of Directors from eleven to twelve members and appointed Thomas Lynch as a Class I director, effective June 2, 2026. Dr. Lynch will serve on the Human Capital Committee and will receive compensation consistent with other non-employee directors. Natera, Inc. operates in the healthcare technology sector, providing genetic testing services.
More from Natera, Inc. Natera raises 2026 revenue guidance by $140M to $3.005B-$3.035B as Q3 sales jump 34% Nov 5, 2026 Natera reported second quarter 2026 financial results with total revenues of $752.8 million, a 37.7% increase from the… Aug 6, 2026 Monica Bertagnolli resigned from the Board of Directors and all associated committees of Natera, Inc., effective July… Jul 6, 2026 On June 11, 2026, Natera, Inc. held its Annual Meeting of Stockholders, where shareholders approved an amendment to… Jun 16, 2026 All content on this site is for informational purposes only and does not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. Always consult a qualified financial advisor before making investment decisions.
Financial data is obtained from public filings and third-party providers and is provided “as-is” without any guarantee of accuracy, completeness, or timeliness.
© 2026 go-intrinsic.com. All rights reserved.
